GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » Cyclically Adjusted PS Ratio

Sysmex (TSE:6869) Cyclically Adjusted PS Ratio : 5.10 (As of May. 24, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Sysmex Cyclically Adjusted PS Ratio?

As of today (2024-05-24), Sysmex's current share price is 円2719.00. Sysmex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円533.10. Sysmex's Cyclically Adjusted PS Ratio for today is 5.10.

The historical rank and industry rank for Sysmex's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:6869' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.36   Med: 7.26   Max: 12.79
Current: 5.16

During the past years, Sysmex's highest Cyclically Adjusted PS Ratio was 12.79. The lowest was 4.36. And the median was 7.26.

TSE:6869's Cyclically Adjusted PS Ratio is ranked worse than
71.46% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs TSE:6869: 5.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sysmex's adjusted revenue per share data for the three months ended in Mar. 2024 was 円216.338. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円533.10 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sysmex Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sysmex's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Cyclically Adjusted PS Ratio Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.27 10.30 6.99 6.01 4.99

Sysmex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.01 6.65 4.69 5.04 4.99

Competitive Comparison of Sysmex's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Sysmex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sysmex's Cyclically Adjusted PS Ratio falls into.



Sysmex Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sysmex's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2719.00/533.1
=5.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sysmex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sysmex's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=216.338/107.2000*107.2000
=216.338

Current CPI (Mar. 2024) = 107.2000.

Sysmex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 75.057 98.000 82.103
201409 84.000 98.500 91.419
201412 90.794 97.900 99.419
201503 104.708 97.900 114.655
201506 92.123 98.400 100.362
201509 102.487 98.500 111.539
201512 102.137 98.100 111.611
201603 106.964 97.900 117.125
201606 94.514 98.100 103.281
201609 95.257 98.000 104.199
201612 99.023 98.400 107.879
201703 110.405 98.100 120.646
201706 98.574 98.500 107.281
201709 110.814 98.800 120.235
201712 114.317 99.400 123.288
201803 125.738 99.200 135.878
201806 105.219 99.200 113.704
201809 112.027 99.900 120.213
201812 115.156 99.700 123.819
201903 135.817 99.700 146.034
201906 109.337 99.800 117.444
201909 118.762 100.100 127.186
201912 119.899 100.500 127.892
202003 133.683 100.300 142.880
202006 96.466 99.900 103.515
202009 114.097 99.900 122.434
202012 127.033 99.300 137.139
202103 148.307 99.900 159.144
202106 126.335 99.500 136.112
202109 142.227 100.100 152.315
202112 143.414 100.100 153.586
202203 166.925 101.100 176.997
202206 137.006 101.800 144.274
202209 171.968 103.100 178.807
202212 166.771 104.100 171.737
202303 177.961 104.400 182.734
202306 151.778 105.200 154.664
202309 186.827 106.200 188.586
202312 181.874 106.800 182.555
202403 216.338 107.200 216.338

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sysmex  (TSE:6869) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sysmex Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sysmex's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (TSE:6869) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines